These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12523657)

  • 1. Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections.
    Barekzi NA; Felts AG; Poelstra KA; Slunt JB; Grainger DW
    Pharm Res; 2002 Dec; 19(12):1801-7. PubMed ID: 12523657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locally delivered antibodies combined with systemic antibiotics confer synergistic protection against antibiotic-resistant burn wound infection.
    Felts AG; Grainger DW; Slunt JB
    J Trauma; 2000 Nov; 49(5):873-8. PubMed ID: 11086779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies.
    Poelstra KA; Barekzi NA; Rediske AM; Felts AG; Slunt JB; Grainger DW
    J Biomed Mater Res; 2002 Apr; 60(1):206-15. PubMed ID: 11835177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model.
    Felts AG; Giridhar G; Grainger DW; Slunt JB
    Burns; 1999 Aug; 25(5):415-23. PubMed ID: 10439150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*.
    Ueda T; Fukunaga K; Seki H; Miyata J; Arita M; Miyasho T; Obata T; Asano K; Betsuyaku T; Takeda J
    Crit Care Med; 2014 Apr; 42(4):e288-95. PubMed ID: 24463858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic induced endotoxin release and clinical sepsis: a review.
    Holzheimer RG
    J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.
    Piano S; Fasolato S; Salinas F; Romano A; Tonon M; Morando F; Cavallin M; Gola E; Sticca A; Loregian A; Palù G; Zanus G; Senzolo M; Burra P; Cillo U; Angeli P
    Hepatology; 2016 Apr; 63(4):1299-309. PubMed ID: 26084406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
    Angeli P; Guarda S; Fasolato S; Miola E; Craighero R; Piccolo F; Antona C; Brollo L; Franchin M; Cillo U; Merkel C; Gatta A
    Aliment Pharmacol Ther; 2006 Jan; 23(1):75-84. PubMed ID: 16393283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
    Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections.
    Falcone M; Paterson D
    J Antimicrob Chemother; 2016 Oct; 71(10):2713-22. PubMed ID: 27432599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice.
    Chopra S; Harjai K; Chhibber S
    Int J Med Microbiol; 2016 Dec; 306(8):707-716. PubMed ID: 27616281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved.
    Ostorhazi E; Holub MC; Rozgonyi F; Harmos F; Cassone M; Wade JD; Otvos L
    Int J Antimicrob Agents; 2011 May; 37(5):480-4. PubMed ID: 21353493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice.
    Fomsgaard A; Holder IA
    APMIS; 1993 Mar; 101(3):229-34. PubMed ID: 8507460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
    Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
    Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
    Blunden M; Zeitlin D; Ashman N; Fan SL
    Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
    Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
    Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin for peritonitis due to gram-negative rods?
    Barrahou M; Goffin E
    Perit Dial Int; 2007; 27(6):710. PubMed ID: 17984438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.